首页> 外文期刊>EFSA Journal >Scientific Opinion on nitrofurans and their metabolites in food
【24h】

Scientific Opinion on nitrofurans and their metabolites in food

机译:食品中硝基呋喃及其代谢物的科学见解

获取原文
           

摘要

Nitrofurans are antimicrobial agents not authorised for use in food‐producing animals in the European Union. Nitrofurans are rapidly metabolised, occurring in animal tissues as protein‐bound metabolites. The European Commission requested EFSA to provide a scientific opinion on the risks to human health related to the presence of nitrofurans in food and whether a reference point for action (RPA) of 1.0 μg/kg for the marker metabolites is adequate to protect public health. Data on occurrence of nitrofuran marker metabolites in food were extracted from the national residue monitoring plan results and from the Rapid Alert System for Food and Feed (RASFF). The CONTAM Panel concluded that these data were too limited to carry out a reliable human dietary exposure assessment. Instead, human dietary exposure was calculated for a scenario in which a single nitrofuran marker metabolite is present at 1.0 μg/kg in foods of animal origin, excluding milk and dairy products. The mean chronic dietary exposure for this worst‐case scenario would range from 3.3 to 8.0 and 1.9 to 4.3 ng/kg b.w. per day for toddlers and adults, respectively. Nitrofurans and their marker metabolites, generally, are genotoxic and carcinogenic and, also, have non‐neoplastic effects in animals. Margins of exposure (MOEs) were calculated at 2.0 × 105 or greater for carcinogenicity and at 2.5 × 103 or greater for non‐neoplastic effects. The CONTAM Panel concluded that it is unlikely that exposure to food contaminated with nitrofuran marker metabolites at or below 1.0 μg/kg is a health concern. A scenario in which foods are considered to be contaminated with semicarbazide, from use of carrageenan as a food additive, at 1 μg/kg was used to assess whether it is appropriate to apply the RPA to foods of non‐animal origin; MOEs of greater than 104 calculated for non‐neoplastic effects do not indicate a health concern.
机译:硝基呋喃是欧洲联盟未获准用于生产食物的动物的抗菌剂。硝基呋喃迅速代谢,在动物组织中以蛋白质结合代谢物的形式出现。欧盟委员会要求欧洲食品安全局(EFSA)就食品中存在硝基呋喃对人体健康的风险以及标记代谢物1.0μg/ kg的参考作用点(RPA)是否足以保护公众健康提供科学意见。食品中硝基呋喃标记代谢物的发生数据是从国家残留物监测计划结果以及食品和饲料快速预警系统(RASFF)中提取的。 CONTAM小组得出结论,这些数据太有限,无法进行可靠的人类饮食暴露评估。取而代之的是,针对在动物源性食品(牛奶和奶制品除外)中单硝基呋喃标记代谢物的含量为1.0μg/ kg的情况,计算了人类的饮食暴露量。在这种最坏情况下,慢性饮食的平均摄入量范围为3.3至8.0 ng / kgb.w。每天分别为幼儿和成人。硝基呋喃及其标志物代谢物通常具有遗传毒性和致癌性,并且在动物中也具有非肿瘤作用。致癌性的接触余量(MOE)计算为2.0×105或更高,非肿瘤效应的接触余量(MOE)为2.5×103或更高。 CONTAM小组得出的结论是,与健康相关的问题不大可能是暴露于浓度低于或等于1.0μg/ kg的被硝基呋喃标记代谢物污染的食物。使用一种以角叉菜胶为食品添加剂,以1μg/ kg的量认为食品被氨基脲污染的场景,用于评估将RPA应用于非动物源性食品是否合适;计算出的非肿瘤效应的MOE大于104并不表示对健康的关注。

著录项

  • 来源
    《EFSA Journal》 |2015年第6期|共217页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号